Kaushik Biswas

Dr. Kaushik Biswas

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2021 in Archives of Microbiology
Verified
Journal Article
Closed access
PDF file
KBKaushik Biswas
Kaushik Biswas
DBDhruba Bhattarcharya
Dhruba Bhattarcharya
MSMalay Saha
Malay Saha
JMJoydeep Mukherjee
Joydeep Mukherjee
SKSanmoy Karmakar
Sanmoy Karmakar


25 August 2025 in Journal of Basic Microbiology
Verified
Journal Article
Closed access
PPPankaj Paul
Pankaj Paul
KBKaushik Biswas
Kaushik Biswas
SVSergio de Los Santos Villalobos
Sergio de Los Santos Villalobos
MUMaria Edith Ortega Urquieta
Maria Edith Ortega Urquieta
DBDhruba Bhattacharya
Dhruba Bhattacharya
HKHariom Kushwaha
Hariom Kushwaha

10 October 2025 in Chemistry & Biodiversity
Verified
Journal Article
Closed access
PPPankaj Paul
Pankaj Paul
SDSandip Dolui
Sandip Dolui
SISumee Ireen
Sumee Ireen
SBSubhadip Bisoi
Subhadip Bisoi
SPSangita Palai
Sangita Palai
KBKaushik Biswas
Kaushik Biswas

5 July 2026 in Future Microbiology
Verified
Journal Article
Closed access
SRSomnath Roy
Somnath Roy
PPPankaj Paul
Pankaj Paul
RSRuchita Santra
Ruchita Santra
SDSandip Dolui
Sandip Dolui
APAritra Pramanik
Aritra Pramanik
KBKaushik Biswas
Kaushik Biswas
To explore the mechanism involved in the inhibition of biofilm formation and antibacterial action of endophytic Streptomyces sp. isolated from the Indian Sundarbans Mangrove Forest. In this study, Streptomyces sp. KJ7TB2 was isolated from the Indian Sundarbans. An ethyl acetate extract was subjected for GC-MS profiling. The mechanisms of antibacterial and antibiofilm action were also explored. In-silico molecular docking and dynamics simulation analyses were performed. The GC-MS analysis of the extract revealed 14 distinct bioactive secondary metabolites. The extract exhibited potent MIC values of 250 μg/mL and 125 μg/mL against Escherichia coli MTCC 1195 and Pseudomonas aeruginosa ATCC 27853. Antibiofilm investigation further revealed inhibition of biofilm formation in both pathogens especially in E. coli MTCC 1195, likely by disrupting initial surface adhesion and exopolysaccharide synthesis. Also, the extract inhibited swarming motility, suggesting interference with flagella-driven motility and quorum sensing. The brine shrimp lethality assay confirmed a favorable safety profile, recording limited mortality (36.84% at 2×MIC over 24 h). In-silico molecular docking and dynamics simulation analyses exhibited robust affinity for two key biofilm-associated proteins, exhibiting significant binding energy (ΔG). The study highlights Streptomyces sp. KJ7TB2 as a potential source for the discovery of safe, potent therapeutics.